|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||
|
|||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Human Ephrin-A1 (aa 18-182) |
| EPLG1 Swiss Prot# | | P20827 |
| EPLG1 Protein names | | Ephrin-A1 (EPH-related receptor tyrosine kinase ligand 1) (LERK-1) (Immediate early response protein B61) (Tumor necrosis factor, alpha-induced protein 4) |
| EPLG1 Gene names | | EFNA1 (EPLG1) (LERK1) (TNFAIP4) |
| Organism | | Human |
| EPLG1 Entry name | | EFNA1_HUMAN |
| EPLG1 Codon optimized cDNA(gene) Clone |
| EPLG1 Cat # | | RPC0049 |
| Tag | | EPLG1 contains A 6x histidine tag |
| EPLG1 Formulation | | Liquid |
| EPLG1 Storage | | Storage at -20℃ to −80℃ Upon receipt. Avoid repeated freeze-thaw cycles. |
| EPLG1 Applications | | Applications: 1. Codon-optimized cDNA(gene) sequence designed for protein production in both E.coli and Mammalian cell. The cDNA(gene) has been cloned into E.coli expression vector with 6x Histidine tag.2. May be used as RNAi assistance to restore the loss-of-function. |
| Recombinant EPLG1 Protein |
| EPLG1 Cat # | | PC0049 |
| EPLG1 Source | | recombinant |
| EPLG1 Applications | | Western Blot, SDS-Page or may be used for other applications determined by user |
| EPLG1 Purity | | >90%, as determined by SDS-PAGE under reducing conditions |
| EPLG1 Activity | | N/A |
| Tag | | EPLG1 Contains A 6x histidine tag |
| EPLG1 Formulation | | Liquid |
| EPLG1 Storage | | ;. Storage at -20℃ to −80℃ Upon receipt. Avoid repeated freeze-thaw cycles. |
| Place Order for Recombinant EPLG1 Products | | For pricing and availability Click Here >>> |
| EPLG1 family | | Ephrin family |
| EPLG1 Subcellular locations | | Cell membrane; Lipid-anchor > GPI-anchor. Secreted. |
| EPLG1 FUNCTION According to UniProtKB Swiss Prot | | FUNCTION: Plays an important role in angiogenesis and tumor neovascularization. The recruitement of VAV2, VAV3 and PI3-kinase p85 subunit by phosphorylated EPHA2 is critical for EFNA1-induced RAC1 GTPase activation and vascular endothelial cell migration and assembly (By similarity). Exerts anti-oncogenic effects in tumor cells through activation and down-regulation of EPHA2. Activates EPHA2 by inducing tyrosine phosphorylation which leads to its internalization and degradation. Acts as a negative regulator in the tumorigenesis of gliomas by down-regulating EPHA2 and FAK. Can evoke collapse of embryonic neuronal growth cones. |
| EPLG1 Sequence | | DDBJ | EMBL | GenBank |
| EPLG1 3D structure | | ModBase |
| EPLG1 interaction | | STRING |
| EPLG1 Proteomic | | PRIDE |
| EPLG1 Genome annotation | | Ensembl | GeneID | KEGG | UCSC |
| EPLG1 Organism specific | | CTD | MGI |
| EPLG1 Phylogenomics | | eggNOG | GeneTree | HOGENOM | HOVERGEN |
| | InParanoid | OrthoDB | PhylomeDB | OMA |
| EPLG1 Gene expression | | Bgee | ArrayExpress | Genevestigator |
| EPLG1 Family and domain | | InterPro | PROSITE | ProtoNet |
| FOR in vitro RESEARCH USE ONLY |